Kercheville Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$245K	Hold	4,037	–	–	0.08%	89
2025 Q4	$222K	Buy	+4,037	New	+$194K	0.06%	105
2025 Q2	–	Sell	-9,001	Closed	-$549K	–	107
2025 Q1	$549K	Buy	9,001 +5,305	+144%	+$309K	0.22%	58
2024 Q4	$209K	Buy	+3,696	New	+$207K	0.08%	82
2024 Q2	–	Sell	-3,778	Closed	-$205K	–	86
2024 Q1	$205K	Buy	+3,778	New	+$192K	0.1%	75
2023 Q4	–	Sell	-9,354	Closed	-$543K	–	82
2023 Q3	$543K	Sell	9,354 -2,647	-22%	-$162K	0.34%	42
2023 Q2	$767K	Sell	12,001 -365	-3%	-$24.5K	0.46%	40
2023 Q1	$857K	Sell	12,366 -1,880	-13%	-$133K	0.59%	38
2022 Q4	$1.02M	Buy	14,246 +4	+0%	+$302	0.71%	32
2022 Q3	$1.01M	Sell	14,242 -346	-2%	-$25.1K	1.03%	29
2022 Q2	$1.12M	Sell	14,588 -10,480	-42%	-$798K	0.74%	30
2022 Q1	$1.83M	Buy	25,068 +10,287	+70%	+$691K	0.87%	27
2021 Q4	$922K	Sell	14,781 -870	-6%	-$51K	0.4%	50
2021 Q3	$926K	Sell	15,651 -7,806	-33%	-$514K	0.44%	54
2021 Q2	$1.57M	Buy	23,457 +258	+1%	+$16.8K	0.73%	40
2021 Q1	$1.46M	Sell	23,199 -13,717	-37%	-$853K	0.73%	41
2020 Q4	$2.27M	Buy	+36,916	New	+$2.27M	1.24%	23